MON-120 Effect of Weight Loss on Physical Function Measured by the 6-Minute Walking Distance Test in Individuals with Obesity: Results from the SCALE IBT Trial of Liraglutide 3.0 M...

por Rubino, Domenica, Shaw Tronieri, Jena, Sugimoto, Daniel, Lund, Michael, Satylganova, Altynai, Zeuthen, Niels, Wadden, Thomas
Publicado 2019

Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trial...

por Heerspink, Hiddo J.L., Apperloo, Ellen, Davies, Melanie, Dicker, Dror, Kandler, Kristian, Rosenstock, Julio, Sørrig, Rasmus, Lawson, Jack, Zeuthen, Niels, Cherney, David
Publicado 2023

Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses

por Kosiborod, Mikhail N., Bhatta, Meena, Davies, Melanie, Deanfield, John E., Garvey, W. Timothy, Khalid, Usman, Kushner, Robert, Rubino, Domenica M., Zeuthen, Niels, Verma, Subodh
Publicado 2022

Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study

por Wilding, John P H, Batterham, Rachel L, Calanna, Salvatore, Van Gaal, Luc F, McGowan, Barbara M, Rosenstock, Julio, Tran, Marie T D, Wharton, Sean, Yokote, Koutaro, Zeuthen, Niels, Kushner, Robert F
Publicado 2021

Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide 2.4 MG in Adults With Overweight or Obesity (STEP 1)

por Wilding, John P H, Batterham, Rachel L, Calanna, Salvatore, Davies, Melanie, Van Gaal, Luc F, Lingvay, Ildiko, McGowan, Barbara M, Rosenstock, Julio, Tran, Marie T D, Wadden, Thomas A, Wharton, Sean, Yokote, Koutaro, Zeuthen, Niels, Kushner, Robert F
Publicado 2021